New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
Expanded EBLIS study with up to 12 years of clinical follow-up across all subtypes of breast cancer ...
Source: marketscreener.com
Ann Oncol News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ann Oncol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ann Oncol Today - Breaking & Trending Today
Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy
HUDDERSFIELD, UK / ACCESSWIRE / November 16, 2022 / Paxman Coolers Limited, MedTech company and manufacturer of the Paxman Scalp Cooling System - cryotherapy technology to mitigate the risk of chemotherapy-induced
Source: finanznachrichten.de
Novartis announces tislelizumab demonstrated efficacy and tolerability in first-line advanced liver cancer in Phase III trial
RATIONALE 301 trial met its objective at final analysis, demonstrating non-inferior overall survival (OS) for tislelizumab (median OS: 15.9 months) versus sorafenib (median OS: 14
Source: pressreleasepoint.com
Novartis Pharma AG: Novartis Kymriah demonstrates strong responses in high-risk patients with relapsed or refractory follicular lymphoma in extended study follow-up
Complete and overall response rates and durability of response were well maintained across majority of high-risk subgroups with a significant unmet need1 Median follow-up of approximately 17 months
Source: finanznachrichten.de
Cervical Cancer immunisation in schools a victim of the pandemic
Though Ireland was making progress in the management of cervical cancer – albeit from a low position internationally – the pandemic has taken its toll
Source: imt.ie